Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(2)

Valsartan (Diovan)

1 trial

phase_4

radboud-university-medical-center

cardiac MRI

1 trial

not_applicable

radboud-university-medical-center

2 unique interventions1 categories

Analytics

Trial Phases

Phase 41

Trial Status

Terminated1

Other1

Role Distribution

Principal Investigator1

Other Roles1

PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04335786Phase 4Terminated

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Acute Respiratory Distress SyndromeCOVIDCOVID-19+2 more

StudychairStart date: 2020-04-17

NCT04281771Not ApplicableActive Not Recruiting

Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI

Acquired Von Willebrand DiseaseAortic Valve InsufficiencyAortic Valve Stenosis+3 more

PrincipalinvestigatorStart date: 2019-09-17

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Acquired Von Willebrand Disease1 Respiratory Distress Syndrome, Acute1 Aortic Valve Insufficiency1 Aortic Valve Stenosis1 COVID1 COVID-191 Hemodynamic Monitoring1 Heyde's Syndrome1

Affiliations

Radboud University Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

COVID-19COVIDSARS-CoV-2

Similarity Score8%

Helen Heslop, MD

Baylor College of Medicine

17 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteCOVID-19SARS-CoV-2

Similarity Score8%

Lorenzo Berra, MD

Massachusetts General Hospital

16 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, AcuteSevere Acute Respiratory Syndrome

Similarity Score5%

David Crowley, MD

KGK Science Inc.

54 trials

Shared therapeutic areas:

COVIDCOVID-19

Similarity Score5%

Mike Royal, MD

Sorrento Therapeutics, Inc.

19 trials

Shared therapeutic areas:

COVID-19Respiratory Distress Syndrome, Acute

Similarity Score5%

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

COVID-19

Similarity Score3%

Matthieu Jabaudon

University Hospital, Clermont-Ferrand

8 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Acute

Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

16 trials

Shared therapeutic areas:

COVID-19

Similarity Score3%

Mohamed mamdouh Elsayed, MD

Lecturer

11 trials

Shared therapeutic areas:

COVID-19

Similarity Score3%

Ron Waksman, MD

Medstar Health Research Institute

18 trials

Shared therapeutic areas:

Aortic Valve Stenosis

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04335786Phase 4StudyChair

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Acute Respiratory Distress SyndromeCOVIDCOVID-19+2 more

Terminated

NCT04281771Not ApplicablePrincipalInvestigator

Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI

Acquired Von Willebrand DiseaseAortic Valve InsufficiencyAortic Valve Stenosis+3 more

Active Not Recruiting

All 2 trials loaded